A5076849007- Prostate Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Renal and related cancers
- Urological Disorders and Treatments
- Urinary and Genital Oncology Studies
- Testicular diseases and treatments
- Renal and Vascular Pathologies
- Surgical Simulation and Training
- Urologic and reproductive health conditions
- Urinary Bladder and Prostate Research
- Adrenal and Paraganglionic Tumors
- Multiple and Secondary Primary Cancers
- Hormonal Regulation and Hypertension
- Infectious Disease Case Reports and Treatments
- Urinary Tract Infections Management
- MRI in cancer diagnosis
- Minimally Invasive Surgical Techniques
- Advanced MRI Techniques and Applications
- Venous Thromboembolism Diagnosis and Management
- Sarcoma Diagnosis and Treatment
- Pelvic floor disorders treatments
- Cancer, Hypoxia, and Metabolism
- Colorectal Cancer Surgical Treatments
Ospedale Policlinico San Martino
2020-2025
Université de Montréal
2022-2025
University of Genoa
2020-2025
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2020-2024
Ospedale Maggiore
2024
Cytodiagnostics (Canada)
2024
Centre Hospitalier de l’Université de Montréal
2023
University of Turin
2020
The aim of this series was to evaluate predictors Proficiency score (PS) achievement on a multicentric robot-assisted radical prostatectomies (RARP) performed by trainee surgeons with two different surgical techniques at four tertiary-care centers.Four institutional datasets were merged and queried for RARPs during their learning curve (LC) between 2010 2020 using approaches (Group A, Retzius-sparing RARP, n = 164; Group B, standard anterograde 79). Logistic regression analysis identify PS...
Head-to-head comparisons between ileal conduit (IC) and orthotopic neobladder (ONB) in terms of peri- postoperative outcomes complications, the specific setting robot-assisted radical cystectomy (RARC), are not available.To address impact type urinary diversion (UD, IC vs ONB) on RARC morbidity, as well operative time (OT), length stay (LOS), readmissions.Urothelial bladder cancer patients treated with at nine high-volume European institutions 2008 2020 were identified.RARC either or...
Retzius-sparing (RS) robot-assisted radical prostatectomy represents a valid surgical treatment option for prostate cancer (PCa) patients. However, the available evidence on role of RS in high-risk (HR) PCa setting is sparse.To describe our technique HR-PCa patients and to evaluate intra-, peri-, postoperative oncological functional outcomes.A total 340 D'Amico underwent at single high-volume centre between 2011 2020.Surgical procedures were performed by five experienced robotic...
Abstract To test for rates of inpatient palliative care (IPC) in metastatic testicular cancer patients receiving critical therapy (CCT). Within the Nationwide Inpatient Sample (NIS) database (2008–2019), we tabulated IPC CCT, namely invasive mechanical ventilation (IMV), percutaneous endoscopic gastrostomy tube (PEG), dialysis acute kidney failure (AKF), total parenteral nutrition (TPN) or tracheostomy. Univariable and multivariable logistic regression models addressing were fitted. Of 420...
Introduction: We aimed to test the impact of International Society Urological Pathology (ISUP) grade group (GG) on cancer-specific mortality (CSM) in organ-confined (pT2) prostate cancer (PCa) at radical prostatectomy (RP). Methods: RP patients were identified (Surveillance, Epidemiology, and End Results 2004−2015). Cancer-specific survival (CSS) rates tested Kaplan-Meier plots multivariable Cox regression (MCR) models according GG: 1–3 vs. 4 5. Sensitivity analyses addressed GG4 GG5 with...
Guidelines suggest less favorable cancer control outcomes for local tumor destruction in T1a renal cell carcinoma patients with size 3.1-4 cm. We compared cancer-specific mortality between cryoablation vs heat-based thermal ablation cm, as well ≤3 cm.Within the Surveillance, Epidemiology, and End Results database (2004-2018), we identified clinical stage treated or ablation. After up to 2:1 ratio propensity score matching ablation, addressed relying on competing risks regression models,...
Background: Intraoperative complications (ICs) are invariably underreported in urological surgery despite the recent endorsement of new classification systems. We aimed to provide a detailed overview ICs during Retzius-sparing robot-assisted radical prostatectomy (RS-RARP). Methods: prospectively collected data from 1891 patients who underwent RS-RARP at single high-volume European center January 2010 December 2022. were based on reports and categorized according Adverse Incident...
The study aim was to report the results of Retzius-Sparing robot-assisted radical Prostatectomy (RSP) in high-risk prostate cancer (HR-PCa) patients a multicentric setting expert surgeons and analyze predictors positive surgical margins (PSMs) urinary continence recovery.We retrospectively evaluated all consecutive HR-PCa who underwent RSP by 7 centers. Pre-, peri- postoperative features were collected. Minimum experience required 100 cases. oncological outcomes PSMs biochemical relapse...
This study aimed to test for temporal trends of in-hospital venous thromboembolism (VTE) and pulmonary embolism (PE) after major urologic cancer surgery (MUCS).In the Nationwide Inpatient Sample (NIS) database (2010-2019), this identified non-metastatic radical cystectomy (RC), prostatectomy (RP), nephrectomy (RN), partial (PN) patients. Temporal VTE PE multivariable logistic regression analyses (MLR) addressing or PE, mortality with were performed.Of 196,915 patients, 1180 (1.0%) exhibited...